Jasper Therapeutics, Inc. - Common Stock, $0.001 Par Value (JSPR) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q4 2025

Type / Class
Equity / Common Stock, $0.001 Par Value
Symbol
JSPR on Nasdaq
Shares outstanding
27,913,938
Price per share
$1.79
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
20,155,606
Total reported value
$47,815,876
% of total 13F portfolios
0%
Share change
+7,641,312
Value change
+$13,373,881
Number of holders
60
Price from insider filings
$1.79
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Jasper Therapeutics, Inc. - Common Stock, $0.001 Par Value (JSPR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Velan Capital Investment Management LP 9.6% $7,578,242 2,668,395 Velan Capital Investment Management LP 19 Sep 2025
T. Rowe Price Investment Management, Inc. 7.1% $4,897,117 2,057,612 T. Rowe Price Investment Management, Inc. 30 Sep 2025
ACORN BIOVENTURES, L.P. 6.4% $4,162,526 1,786,492 Anders Hove 01 Dec 2025
Soleus Capital Master Fund, L.P. 10% $5,409,800 1,494,420 Soleus Capital Management, L.P. 31 Dec 2024
KINGDON CAPITAL MANAGEMENT, L.L.C. 4.7% -8% $3,153,131 +$1,332,431 1,324,845 +73% Kingdon Capital Management, L.L.C. 30 Sep 2025
Qiming U.S. Healthcare Fund II, L.P. 3.3% $2,210,934 928,964 Qiming U.S. Healthcare Fund II, L.P. 30 Sep 2025
MORGAN STANLEY 2.8% -44% $1,867,415 +$62,296 784,628 +3.5% Morgan Stanley 30 Sep 2025
BlackRock, Inc. 1.5% $1,019,735 225,605 BlackRock, Inc. 30 Jun 2025

As of 30 Sep 2025, 60 institutional investors reported holding 20,155,606 shares of Jasper Therapeutics, Inc. - Common Stock, $0.001 Par Value (JSPR). This represents 72% of the company’s total 27,913,938 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Jasper Therapeutics, Inc. - Common Stock, $0.001 Par Value (JSPR) together control 70% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Velan Capital Investment Management LP 9.6% 2,668,395 +86% 5.8% $6,205,880
Soleus Capital Management, L.P. 5.4% 1,494,420 0% 0.19% $3,556,720
ACORN CAPITAL ADVISORS, LLC 5% 1,382,640 1.7% $3,290,683
KINGDON CAPITAL MANAGEMENT, L.L.C. 4.7% 1,324,845 +93% 0.49% $3,153,131
Rock Springs Capital Management LP 3.9% 1,100,726 +102% 0.15% $2,619,728
Carlyle Group Inc. 3.8% 1,066,189 0% 0.06% $2,526,868
Woodline Partners LP 3.7% 1,039,751 0.01% $2,474,607
VANGUARD GROUP INC 3.7% 1,032,842 +65% 0% $2,458,164
T. Rowe Price Investment Management, Inc. 3.7% 1,028,806 +46% 0% $2,449,000
Propel Bio Management, LLC 3.7% 1,028,806 2.5% $2,448,558
QIMING U.S. VENTURES MANAGEMENT, LLC 3.3% 928,964 0% 4% $2,210,934
MORGAN STANLEY 2.8% 789,960 +2.6% 0% $1,880,105
SPHERA FUNDS MANAGEMENT LTD. 2.3% 629,470 +4191% 0.36% $1,498,139
Simplify Asset Management Inc. 2.2% 609,053 0.03% $1,449,546
CITADEL ADVISORS LLC 2.1% 589,449 +44% 0% $1,402,889
BOOTHBAY FUND MANAGEMENT, LLC 1.6% 442,642 0.03% $1,053,488
Lion Point Capital, LP 1.4% 398,558 +172% 5.4% $948,568
MILLENNIUM MANAGEMENT LLC 1.3% 364,939 +151% 0% $868,555
ARMISTICE CAPITAL, LLC 1.2% 348,000 0.03% $828,240
BANK OF AMERICA CORP /DE/ 1.1% 294,553 +0.37% 0% $701,036
RENAISSANCE TECHNOLOGIES LLC 0.75% 208,500 +1905% 0% $496,230
BlackRock, Inc. 0.73% 204,932 -9.2% 0% $487,738
Knott David M Jr 0.61% 171,389 0.17% $407,906
DEUTSCHE BANK AG\ 0.57% 160,000 0% 0% $380,800
GEODE CAPITAL MANAGEMENT, LLC 0.47% 130,855 -0.21% 0% $311,559

Institutional Holders of Jasper Therapeutics, Inc. - Common Stock, $0.001 Par Value (JSPR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$7,378 $1.79 0
2025 Q3 20,155,606 $47,815,876 +$13,373,881 $2.38 60
2025 Q2 12,514,434 $69,456,410 -$2,535,021 $5.55 63
2025 Q1 13,034,173 $56,047,403 -$70,633,611 $4.30 66
2024 Q4 15,646,434 $334,366,183 +$15,008,655 $21.38 84
2024 Q3 14,676,954 $274,621,162 -$5,485,863 $18.81 77
2024 Q2 14,557,013 $329,580,336 +$34,892,996 $22.70 68
2024 Q1 12,950,959 $379,146,145 +$359,441,971 $29.36 56
2023 Q4 494,706 $390,323 +$390,323 $0.79 1